(Q37871341)

24 August 2017

1 reference

title

Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers (English)

1 reference

24 August 2017

0 references

0 references

David J A Goldsmith

1

1 reference

24 August 2017

John Cunningham

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

3 May 2011

1 reference

Nature Reviews Nephrology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

341-346

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2011.53

24 August 2017

exact match

0 references

cites work

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Extraordinary popular delusions and the madness of crowds: puncturing the epoetin bubble--lessons for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Association of activated vitamin D treatment and mortality in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Mineral and bone disorder and outcomes in hemodialysis patients: results from the DOPPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Vitamin D: evolutionary, physiological and health perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Clinical relevance of FGF-23 in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

The virtues of vitamin D--but how much is too much?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Impact of activated vitamin D and race on survival among hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

FGF-23: More than a regulator of renal phosphate handling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Accelerated atherosclerosis in prolonged maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Vascular calcification in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Mortality risk among hemodialysis patients receiving different vitamin D analogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Negative outcome studies in end-stage renal disease: how dark are the storm clouds?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.53

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21537350

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21537350

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEPH.2011.53

1 reference

Dimensions Publication ID

24 August 2017

1030343866

0 references

1 reference